Home > Research > Researchers > Professor David Allsop > Publications

Research

Professor David Allsop

Formerly at Lancaster University

81 - 90 out of 154Page size: 10
RSS feed of this list
  1. 2003
  2. Published

    Generation of hydrogen peroxide from mutant forms of the prion protein fragment PrP121-231.

    Turnbull, S., Tabner, B. J., Brown, D. R. & Allsop, D., 1/07/2003, In: Biochemistry. 42, 25, p. 7675-7681 7 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  3. Published

    Soluble oligomers for the diagnosis of neurodegenerative diseases.

    El-Agnaf, O. M. A., Walsh, D. M. & Allsop, D., 08/2003, In: Lancet Neurology. 2, 8, p. 461-462 2 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  4. Published

    Quinacrine acts as an antioxidant and reduces the toxicity of the prion peptide PrP106-126.

    Turnbull, S., Tabner, B. J., Brown, D. R. & Allsop, D., 15/09/2003, In: NeuroReport. 14, 13, p. 1743-1745 3 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  5. Published

    α-Synuclein implicated in Parkinson’s disease is present in extracellular biological fluids, including human plasma.

    El-Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Cooper, L. J., Fullwood, N. J., Gibson, M. J., Curran, M. D., Court, J. A., Mann, D. M. A., Ikeda, S-I., Cookson, M. R., Hardy, J. & Allsop, D., 10/2003, In: FASEB Journal. 17, 13, p. 1945-1947 3 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  6. Published

    Fe(II)-induced DNA damage in α-synuclein-transfected human dopaminergic BE(2)-M17 neuroblastoma cells: detection by the Comet assay.

    Martin, F., Williamson, S. J. M., Paleologou, K. E., Hewitt, R., El-Agnaf, O. M. A. & Allsop, D., 11/2003, In: Journal of Neurochemistry. 87, 3, p. 620-630 11 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  7. 2004
  8. Published

    Induction of cellular oxidative stress by the β-amyloid peptide involved in Alzheimer's disease.

    Gibson, G. L., Allsop, D. & Austen, B. M., 2004, In: Protein and Peptide Letters. 11, 3, p. 257-270 14 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  9. Published

    α-Synuclein and the pathogenesis of Parkinson’s disease.

    Martin, F., Allsop, D., Williamson, S. J. M., Paleologou, K. E. & El-Agnaf, O. M. A., 2004, In: Protein and Peptide Letters. 11, 3, p. 229-237 9 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  10. Published

    Both the D-(+) and L-(-) enantiomers of nicotine inhibit Aβ aggregation and cytotoxicity.

    Moore, S. A., Huckerby, T. N., Gibson, G. L., Fullwood, N. J., Turnbull, I., Tabner, B. J., El-Agnaf, O. M. A. & Allsop, D., 01/2004, In: Biochemistry. 43, 3, p. 819-826 8 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  11. Published

    A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.

    El-Agnaf, O. M. A., Paleologou, K. E., Greer, B., Abogrein, A. M., King, J., Salem, S. A., Fullwood, N. J., Benson, F. E., Hewitt, R., Ford, K. J., Martin, F., Harriott, P., Cookson, M. R. & Allsop, D., 08/2004, In: FASEB Journal. 18, 11, p. 1315-1317 3 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  12. 2005
  13. Published

    The production of hydrogen peroxide during early-stage protein aggregation: a common pathological mechanism in different neurodegenerative diseases?

    Tabner, B., Turnbull, S., Fullwood, N. J., German, M. & Allsop, D., 08/2005, In: Biochemical Society Transactions. 33, 4, p. 548-550 3 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

Previous 1...5 6 7 8 9 10 11 12 ...16 Next

Back to top